These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 24438678)

  • 1. Relationship between polymorphisms near the IL28B gene and spontaneous HBsAg seroclearance: a systematic review and meta-analysis.
    Lee DH; Lee JH; Kim YJ; Park NH; Cho Y; Lee YB; Yoo JJ; Lee M; Cho YY; Choi WM; Yu SJ; Yoon JH; Kim CY; Lee HS
    J Viral Hepat; 2014 Mar; 21(3):163-70. PubMed ID: 24438678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DP and IL28B polymorphisms: influence of host genome on hepatitis B surface antigen seroclearance in chronic hepatitis B.
    Seto WK; Wong DK; Kopaniszen M; Proitsi P; Sham PC; Hung IF; Fung J; Lai CL; Yuen MF
    Clin Infect Dis; 2013 Jun; 56(12):1695-703. PubMed ID: 23449268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High hepatitis B virus surface antigen levels and favorable interleukin 28B genotype predict spontaneous hepatitis C virus clearance in uremic patients.
    Yu ML; Dai CY; Huang CF; Lee JJ; Yeh ML; Yeh SM; Kuo HT; Huang JF; Chang JM; Chen HC; Juo SH; Hwang SJ; Chuang WL;
    J Hepatol; 2014 Feb; 60(2):253-9. PubMed ID: 24096049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between IL28B Polymorphisms and Outcomes of Hepatitis B Virus Infection: A meta-analysis.
    Zhao J; Zhang X; Fang L; Pan H; Shi J
    BMC Med Genet; 2020 May; 21(1):88. PubMed ID: 32357928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-nucleotide polymorphism of rs7944135 (macrophage-expressed gene 1) is associated with hepatitis B surface antigen seroclearance in chronic hepatitis B infection: A cohort study.
    Irham LM; Wong HS; Perwitasari DA; Chou WH; Yang HI; Chang WC
    Medicine (Baltimore); 2019 Dec; 98(51):e17936. PubMed ID: 31860948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL28B polymorphisms predict interferon-related hepatitis B surface antigen seroclearance in genotype D hepatitis B e antigen-negative patients with chronic hepatitis B.
    Lampertico P; Viganò M; Cheroni C; Facchetti F; Invernizzi F; Valveri V; Soffredini R; Abrignani S; De Francesco R; Colombo M
    Hepatology; 2013 Mar; 57(3):890-6. PubMed ID: 22473858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms near IL28B and serologic response to peginterferon in HBeAg-positive patients with chronic hepatitis B.
    Sonneveld MJ; Wong VW; Woltman AM; Wong GL; Cakaloglu Y; Zeuzem S; Buster EH; Uitterlinden AG; Hansen BE; Chan HL; Janssen HL
    Gastroenterology; 2012 Mar; 142(3):513-520.e1. PubMed ID: 22108195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of IFNL3 genotype on interferon treatment outcome in patients chronically infected with hepatitis B virus: A meta-analysis.
    Zhao Z; Qin Z; Zhou L; Xiang L; You J; Cao R; Wang H; Wang B; Li M
    Microb Pathog; 2019 Sep; 134():103598. PubMed ID: 31201901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-28 gene polymorphisms may contribute to HBsAg persistence and the development of HBeAg-negative chronic hepatitis B.
    Karataylı SC; Bozdayı M; Karataylı E; Öztürk T; Husseini AA; Albayrak R; Özkan M; Kalaylıoğlu Z; Yalçın K; Çınar K; İdilman R; Yurdaydın C
    Liver Int; 2015 Mar; 35(3):846-53. PubMed ID: 24840315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysis.
    Yeo YH; Ho HJ; Yang HI; Tseng TC; Hosaka T; Trinh HN; Kwak MS; Park YM; Fung JYY; Buti M; Rodríguez M; Treeprasertsuk S; Preda CM; Ungtrakul T; Charatcharoenwitthaya P; Li X; Li J; Zhang J; Le MH; Wei B; Zou B; Le A; Jeong D; Chien N; Kam L; Lee CC; Riveiro-Barciela M; Istratescu D; Sriprayoon T; Chong Y; Tanwandee T; Kobayashi M; Suzuki F; Yuen MF; Lee HS; Kao JH; Lok AS; Wu CY; Nguyen MH
    Gastroenterology; 2019 Feb; 156(3):635-646.e9. PubMed ID: 30342034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of interleukin 28B polymorphisms on spontaneous clearance of hepatitis C virus infection: a meta-analysis.
    Yang M; Rao HY; Feng B; Zhang W; Wei L
    J Gastroenterol Hepatol; 2013 Jul; 28(7):1114-21. PubMed ID: 23611115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-λ gene polymorphisms as predictive factors in chronic hepatitis C treatment-naive patients without access to protease inhibitors.
    Olmedo DB; Cader SA; Porto LC
    J Med Virol; 2015 Oct; 87(10):1702-15. PubMed ID: 25970604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene polymorphisms of interleukin 28B and the risk to chronic hepatitis B virus infection in Thai.
    Kimkong I; Chankaew J; Kunanopparat A; Hirankarn N; Tangkijvanich P
    Tissue Antigens; 2015 Mar; 85(3):177-81. PubMed ID: 25664396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variation in interleukin 28B and correlation with chronic hepatitis B virus infection in Saudi Arabian patients.
    Al-Qahtani AA; Al-Anazi MR; Abdo AA; Sanai FM; Al-Hamoudi WK; Alswat KA; Al-Ashgar HI; Khalaf NZ; Viswan NA; Al Ahdal MN
    Liver Int; 2014 Aug; 34(7):e208-16. PubMed ID: 24118788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of associations of interleukin-28B polymorphisms rs8099917 and rs12979860 with development of hepatitis virus-related hepatocellular carcinoma.
    Zhang Y; Zhu SL; Chen J; Li LQ
    Onco Targets Ther; 2016; 9():3249-57. PubMed ID: 27313470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of IL28-B polymorphisms in the treatment of chronic hepatitis B HBeAg-negative patients with peginterferon.
    Boglione L; Cusato J; Allegra S; Esposito I; Patti F; Cariti G; Di Perri G; D'Avolio A
    Antiviral Res; 2014 Feb; 102():35-43. PubMed ID: 24316030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms near interleukin 28B gene are not associated with hepatitis B virus clearance, hepatitis B e antigen clearance and hepatocellular carcinoma occurrence.
    Lee DH; Cho Y; Seo JY; Kwon JH; Cho EJ; Jang ES; Kwak MS; Cheong JY; Cho SW; Lee JH; Yu SJ; Yoon JH; Lee HS; Kim CY; Shin HD; Kim YJ
    Intervirology; 2013; 56(2):84-90. PubMed ID: 23343781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel susceptibility loci associated with hepatitis B surface antigen seroclearance in chronic hepatitis B.
    Kim TH; Lee EJ; Choi JH; Yim SY; Lee S; Kang J; Lee YR; Lee HA; Choi HS; Kim ES; Keum B; Seo YS; Yim HJ; Jeen YT; Chun HJ; Lee HS; Kim CD; Woo HG; Um SH
    PLoS One; 2018; 13(7):e0199094. PubMed ID: 29975729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL28B gene polymorphism rs12979860, but not rs8099917, contributes to the occurrence of chronic HCV infection in Uruguayan patients.
    Echeverría N; Chiodi D; López P; Sanchez Ciceron A; Angulo J; López-Lastra M; Silvera P; Canavesi A; Bianchi C; Colistro V; Cristina J; Hernandez N; Moreno P
    Virol J; 2018 Mar; 15(1):40. PubMed ID: 29499724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFNL4 rs368234815 and rs117648444 variants predict off-treatment HBsAg seroclearance in IFN-treated HBeAg-negative chronic hepatitis B patients.
    Galmozzi E; Facchetti F; Grossi G; Loglio A; Viganò M; Lunghi G; Colombo M; Lampertico P
    Liver Int; 2018 Mar; 38(3):417-423. PubMed ID: 28732143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.